GSK Vaccine Recall: Flulaval – “Might Cause More Harm Than Good”!
- GSK Vaccine Recall: Flulaval – “Might Cause More Harm Than Good”!
by Susanne Posel, http://www.occupycorporatism.com/home/
GlaxoSmithKline (GSK) have ordered a recall of their 4 in 1 vaccine called Flulaval Quadrivalent Thimerosal “due to effectiveness issues”.
–
GSK said “the vaccine might cause more harm than good because it is not good enough to protect someone from the current flu strains present in the US.”
–
Flulaval “was designed” to protect against Type A and B and 2 other flu strains which makes it a quadrivalent vaccine – the new standard in inoculations.
–
GSK admitted in a statement “[we] cannot rule out prospective suboptional protection” for those who received Flulaval in early January of this year or later.
–
This information was disseminated in a letter to GSK clients such as wholesale distributors, pharmacies, government agencies and physicians in the US.
–
Because Flulaval is ineffective, 1.7 million doses are being recalled while GSK conducts testing on the product to prove efficiency.
–
Anna Padula, spokesperson for GSK claims that this recall is in no way “a result of any identified safety concern[s].” The ingredients of Fluval include:
–
• “inactivated” influenza virus
• Formaldehyde
• Sodium Deoxycholate
• Saline solution
• Thimerosal
• Ovalbumin
• Polysorbate
–
GSK markets Flulaval as “a vaccine indicated for active immunization disease”; however does not indicate that the vaccine is effectual.
–
According to the insert for Flulaval, “there have been no controlled trials adequately demonstrating a decrease in influenza disease after vaccination with” this product.
–
Another shocking confession about Flulaval by GSK is that the vaccine has “not been evaluated for carcinogenic or mutagenic potential, [and] impairment of fertility” along with the fact that “safety and effectiveness of Flulaval in pediatric patients [has] not been established” which includes:
–
• Pregnant women
• Women nursing
• children
–
read more!
end